News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GenMark Diagnostics (GNMK) to Show its All-Electronic, Sample-to-Answer Molecular Diagnostics Platform at the Association for Molecular Pathology Meeting



10/22/2012 9:38:24 AM

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics Inc., (NASDAQ: GNMK) a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that it will show a prototype of the Company’s NexGen system, an all-electronic fully integrated molecular diagnostics platform, at the Association of Molecular Pathology (AMP) meeting to be held on October 25-27, 2012 in Long Beach, California.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES